Genetic Analysis wins Canadian patent for IBS diagnostic

Genetic Analysis won a Canadian patent for an in vitro diagnostic to identify IBS patients more likely to respond to fecal microbiota transplantation, using gut microbiota signatures to support treatment selection. Patent protection runs through 2037.